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Twins can be used to investigate the biological basis for observed associations between birth weight and later disease risk, as they experience in utero
growth restriction compared with singletons, which can differ in magnitude within twin pairs despite partial or total genetic identity. In the present
study, sixty monozygotic and seventy-one dizygotic same-sex twin pairs aged 19–50 years and eighty-nine singleton controls matched for age, gestational
age, sex, maternal age and parity were recruited from an obstetric database. Associations between fasting lipid levels and birth weight were assessed by
linear regression with adjustment for possible confounding factors. Twins were significantly lighter at birth but were not significantly different in adult
height, weight or lipid levels from the singleton controls. There was a significant inverse association between birth weight and both total and LDL-choles-
terol levels among singleton controls (20·53 mmol/l per kg (95 % CI 20·97, 20·09), P¼0·02 and 20·39 mmol/l per kg (95 % CI 20·76, 20·02), P¼0·04,
respectively), but there was no significant association between birth weight and lipid levels in either unpaired or within-pair analysis of twins. The results
suggest that the in utero growth restriction and early catch-up growth experienced by twins does not increase the risk of an atherogenic lipid profile in adult
life.
Birth weight: Lipid levels: Twins
An association between birth weight and adult susceptibility to
CVD, diabetes and hypertension has been reported by a number
of groups in widely different cultural settings (Barker
et al. 1993; Curhan et al. 1996; Stein et al. 1996; Rich-Edwards
et al. 1997, 1999; Forsen et al. 1999; Huxley et al. 2000;
Burke et al. 2004). The ‘fetal origins’ hypothesis proposes that
this association is causal as a result of ‘predictive adaptive
responses’ made by the fetus to undernutrition in utero, which
persist into adulthood and increase susceptibility to the metabolic
effects of overnutrition in later life (Barker, 1995, 1998, 1999;
Gluckman & Hanson, 2004). Although in man the evidence for
a close relationship between birth weight and maternal diet is lim-
ited, intervention studies in animals provide support for the possi-
bility that maternal nutrient intake may influence both size at birth
and later disease risk (McMillen & Robinson, 2005).
Although much of the literature on the fetal origins hypothesis has
focused on hypertension and insulin resistance, increased plasma
lipid levels are also a major independent risk factor for CVD
(Poulter, 2003). A systematic review of thirty-two studies in single-
tons found a weak inverse association between birth weight and total
cholesterol (Owen et al. 2003), but a more recent review of seventy-
nine studies concluded that impaired fetal growth does not have
effects on blood cholesterol levels that would have a material
impact on vascular disease risk (Huxley et al. 2004). Another sys-
tematic review of thirty-nine studies, which included other lipid
measures, also concluded that there was no consistent relationship
between size at birth and blood lipid concentrations in later life,
with the possible exception of a negative association between
birth weight and triacylglycerol concentration (Laure`n et al.
2003). Thus, there remains considerable uncertainty as to the
strength of the relationship with birth weight and, if the relationship
does exist, whether fetal undernutrition is the underlying mechan-
ism. One alternative interpretation is that the same genes that predis-
pose to adult disease also result in low birth weight (Hattersley &
Tooke, 1999; Eriksson et al. 2002) as there is evidence that genetic
factors contribute to the variation in birth weight (Magnus, 1984;
Magnus et al. 1997) and lipid levels (Boekholdt et al. 2004). Twin
studies provide an opportunity to separate the influence of the
early environment and the influence of genetic factors, since twins
experience in utero growth restriction and in addition experience
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postnatal catch-up growth, which has been identified as an
additional risk factor for later CVD in singletons (Eriksson et al.
1999). Furthermore, the importance of genetic factors in explaining
an association between birth weight and disease risk can be assessed
by comparing the magnitude of the effect in dizygotic v.monozygo-
tic twin pairs. A recent study of adolescent twins using this approach
found significant correlations in dizygotic but not monozygotic
pairs, which suggested that genetic factors contribute to the relation-
ship between birth weight and later plasma lipid concentrations
(Ijzerman et al. 2001). However, another study found that in mono-
zygotic twin pairs the lower-birth-weight twins tended to have
higher triacylglycerol and lower HDL-cholesterol levels than the
higher-weight twins, suggesting that non-genetic factors play a
role in this relationship (Bo et al. 2001).
We have previously reported the results of a study of adult
twins and singleton controls designed to investigate whether gen-
etic factors contribute to association between size at birth and
blood pressure, insulin resistance and fibrinogen levels in adult
life (McNeill et al. 2003; Tuya et al. 2003, 2005). In the present
paper we explore the relationship between birth weight and fast-
ing lipid concentrations using the same study design. We also
report the total genetic contribution to variation in the lipid
levels based on the classical twin study design.
Methods
Subjects
The Aberdeen Maternity and Neonatal Databank is a compu-
terised register of all births that have occurred at Aberdeen Mater-
nity Hospital in Aberdeen, Scotland, since 1949. It contains
detailed obstetric information including gestation and birth
weight recorded at delivery. Between 1949 and 1980 there were
792 same-sex-twin live births at Aberdeen Maternity Hospital.
Of these, 465 twin pairs (59 %) in which one or both twins
were living in the Grampian region were traced via the local
Community Health Index (a database of all individuals registered
with the National Health Service) in 1999. To identify singleton
controls, each twin delivery was matched with up to four live sin-
gleton deliveries of the same sex, gestational age (^1 week),
maternal age (^5 years) and parity (0, 1 or $2), and year of
birth (^ 1 year). Of these, 442 individuals living in Grampian
were traced through the Community Health Index. In fifteen
twin pairs, one or both twins were excluded by the family
doctor for medical reasons, as was one singleton. All others
were sent a letter of information about the study and 131 twin
pairs (32 %) and ninety-three singletons (21 %) agreed to partici-
pate and attended for measurements. Acute and/or chronic illness
was excluded using a standardised questionnaire. Four singletons
were later excluded from analysis as a result of errors discovered
in the matching of singleton and twin deliveries. The effect of oral
contraceptives on lipid levels was assessed by linear regression
with adjustment for oral contraceptive use. None of the subjects
used any other medication that may affect serum lipid profile.
Thus, 131 twin pairs and eighty-nine singleton controls were eli-
gible for analysis.
Measurements and questionnaire
Measurements were made of height, weight and waist circumfer-
ence in each subject. BMI was calculated (kg/m2). Body fat was
measured by bioelectrical impedance analysis using the Body-
statw 1500 (Bodystat Ltd, Isle of Man). Medical details, smoking
and occupation were obtained by a questionnaire based on that
used in the Scottish MONICA study (Smith et al. 1989). The
physical activity questions were a modified version of those
used for the Framingham Physical Activity Index (Kannel &
Sorlie, 1979). Diet was assessed using version 6.31 of the Scottish
Collaborative Group semi-quantitative food-frequency question-
naire (Masson et al. 2003).
Clinical and laboratory investigations
An overnight fasting venous blood sample was taken for measure-
ments of cholesterol, triacylglycerols and apolipoproteins. Total
cholesterol, HDL-cholesterol and triacylglycerols were measured
on the Bayer ADVIA 1650w (Bayer Healthcare, Newbury, UK)
and LDL-cholesterol was calculated using the Friedewald
equation (Friedewald et al. 1972). Apo A1 and apo B were
measured by in vitro diagnostic reagents N Antisera using the
Behring Rate Nephelometer (Dade Behring Ltd, Milton Keynes,
UK). The interassay CV was ,2 % for total cholesterol and tria-
cylglycerols. For all other assays it was ,5 %. The laboratory
references for all analytes were in the relevant United Kingdom
National Quality Assurance Scheme.
Birth weight, gestational age, maternal age and parity for both
twins and controls were obtained from obstetric records in the
Aberdeen Maternity Neonatal Databank. Self-reported birth
order was used to link the relevant obstetric information from
the Aberdeen Maternity Neonatal Databank to individual twins
from each pair. Zygosity was determined by DNA fingerprinting
using a venous blood sample. Ten short tandem repeats were ana-
lysed using the AmpFLSTR Profiler on the ABI 310 genetic ana-
lyzer (Applied Biosystems, Foster City, CA, USA).
The study protocol was approved by the Grampian Research
Ethics Committee, and all subjects gave informed written consent
to participate.
Statistical analysis
The contribution of genetic and shared and non-shared environ-
mental effects for the total variation in lipid risk factors was
assessed using an ACE twin model using the Mx program
(Neale et al. 2004) for twin data (Purcell, 2000). This partitions
the total variance in a trait into Additive genetic variance and
Common (shared) and unique Environmental effects. The var-
iance–covariance matrix for each of the parameters was calcu-
lated for the monozygotic and dizygotic twins following
adjustment by multiple regression. In the basic model only sex
and age were adjusted for, while in the fully adjusted model the
data were adjusted for sex, age, percentage body fat, dietary poly-
unsaturated:saturated fatty acid ratio, dietary percentage energy as
fat, physical activity level, and the use of oral contraceptives.
Differences in birth weight, anthropometric variables and lipid
measurements between twins and singleton controls were
assessed by Mann–Whitney tests. The relationships between
birth weight and adult lipid levels were assessed by linear
regression with adjustment for current age, sex, gestational age,
percentage body fat, physical activity, oral contraceptive use, per-
centage energy from fat and polyunsaturated:saturated fatty acid
ratio. Regression coefficients for the relationships between lipid
levels and birth weight in the unpaired analysis in twins were
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estimated using generalised estimating equations with an
exchangeable correlation structure to model the correlated
nature of the sample.
In addition, linear regression analysis was used to assess the
association between within-pair differences in birth weight and
differences in lipid levels before and after adjustment for differ-
ences in confounding variables. In within-pair analysis the differ-
ences between first- and second-born twins were used rather than
the differences between heavier and lighter twins at birth, as the
range of birth-weight differences is wider with both positive
and negative values in the former than the latter, which improves
the estimation of the regression coefficient (Bring & Wernroth,
1999). Difference in oral contraceptive use was assessed by
coding twins on oral contraceptive, not on oral contraceptive
but co-twins on oral contraceptive, and not on oral contraceptive,
as 2, 1, and 0 respectively, and subtracting the code for the
second-born twin from that for the first-born twin. These analyses
were carried out using SPSS version 11 (SPSS Inc., Chicago, IL,
USA) and STATA version 7.0 (StataCorp LP, College Station,
TX, USA).
Results
There were no significant differences in current age, birth weight,
gestational age or maternal parity between participants and non-
participants, although the percentage of female twins who partici-
pated was higher than the percentage of male twins (Table 1).
The birth weights, adult characteristics and lipid profile of the
participating twins and singleton controls are shown in Tables 2
and 3. Male participants were slightly older than female partici-
pants in both twins (P,0·001) and singleton controls (P,0·05),
which may reflect difficulties involved in tracing older women
as a result of changes of names on marriage. As expected the sin-
gleton controls (both males and females) had a significantly
higher birth weight than the twins (P,0·001 for both), even
though there was no difference in gestational age. However,
there were no differences in plasma lipid concentrations, adult
height and weight, or BMI between twins and singletons in
either males or females.
Among the twins, birth weight and gestational age were not
significantly different between monozygotic and dizygotic twins
(data not shown), but current age was significantly higher in dizy-
gotic twins than in monozygotic twins among both males and
females (P¼0·05 and P¼0·04, respectively). Adult weight,
BMI, percentage body fat and triacylglycerol levels were also
significantly higher in dizygotic twins than in monozygotic
twins among the males (P¼0·02, P¼0·01, P¼0·005 and
P¼0·006, respectively).
Table 4 shows the results of the ACE analysis, which indicate that
40–50 % of the variance in HDL-cholesterol and apo A1 was
genetically determined. In the case of apo B about 60 % of the vari-
ation was genetically determined, but this effect appeared to be
operating largely via a genetic influence on the percentage body
fat as adjustment for this factor in particular was largely responsible
for the removal of the genetic effect in the fully adjusted model. The
model also calculated a genetic influence on LDL-cholesterol of the
same order of magnitude but this was not significant because of the
high variance in this parameter in the dizygotic twins in particular.
As with apo B, even this non-significant effect was removed after
full adjustment, again largely due to the effect of body fat.
Although there was a wide range of within-pair differences in
birth weight, adult height, BMI and lipid concentrations in all vari-
ables, for example, up to 1·8 kg in birth weight and up to 3·8 mmol/l
in total cholesterol concentrations, the range of within-pair differ-
ences was similar in monozygotic and dizygotic twin pairs (data
not shown). Table 5 shows the regression coefficients for the associ-
ation between birth weight and lipid levels in singletons and twins.
There was a significant negative relationship between within-pair
Table 1. Obstetric data of participating and non-participating twin pairs and singleton controls
(Mean values with their standard errors)
Twin pairs Singleton controls
Participants
(131 twin pairs)
Non-participants
(663 twin pairs)
Participants
(n 89)
Non-participants
(n 478)
Mean SEM Mean SEM P Mean SEM Mean SEM P
Age (years) 33·2 0·80 34·1 0·38 NS 33·7 1·04 31·3 0·42 NS
Gestational age (weeks) 37·2 0·24 37·2 0·10 NS 37·0 0·26 37·4 0·11 NS
Birth weight (g)
First-born 2582 47·73 2498 20·11 NS 2942 62·94 2933 30·46 NS
Second-born 2394 44·02 2351 20·34 NS
Sex
Male pairs
n 53 352 NS 47 261 NS
% 40·5 53·1 52·8 54·6
Female pairs
n 78 311 0·01 42 217 NS
% 59·5 46·9 47·2 45·4
Parity of mother
Primiparous
n 51 229 NS 31 157 NS
% 38·9 34·5 34·8 32·8
Multiparous
n 80 434 NS 58 321 NS
% 61·1 65·5 65·2 67·2
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differences in birth weight and differences in both total and HDL-
cholesterol in monozygotic twins, in the unadjusted analyses
(20·29 mmol/l per kg (95 % CI 20·49, 2 0·09), P¼0·004 and
20·11 mmol/l per kg (95 % CI 0·22, 0·00), P¼0·04, respectively),
but this was not seen in the adjusted models. In the analysis of all
twins, both unadjusted and adjusted regression coefficients were
small and were not statistically significant. However, in singleton
controls, there were significant inverse associations between birth
weight and both total and LDL-cholesterol concentrations in the
adjusted models.
Discussion
Despite the smaller numbers of singleton controls in the present
study, we found a significant inverse association between birth
weight and lipid levels in the singleton controls. This was in line
with the inverse associations between birth weight and diastolic
blood pressure, glycated Hb (HbA1C) and clottable fibrinogen
observed in these subjects (McNeill et al. 2003; Tuya et al. 2003,
2005). The possibility that genetic factors might contribute to this
association was supported by the observation that in the twins the
ACE analysis confirmed the importance of genetic factors in deter-
mining lipid levels. However, in the unpaired analysis in twins we
found no association between birth weight and lipid levels. In
addition there was no difference in lipid levels between the twins
and singleton controls despite the lower birth weight and postnatal
catch-up growth in the twins. Taken together, these results suggest
that the type of intra-uterine growth restriction and postnatal
catch-up growth seen in twins does not have an adverse effect on
lipid levels in later life. Phillips et al. (2001) suggested that small
size at birth in twins may not have the same origin as small size in
singletons, which could be due to the fact that growth restriction
in twins only occurs from about 32 weeks (Loos et al. 2005). Gluck-
man & Hanson (2004) also raised the possibility that maternal con-
straint on fetal growth as a result of increased fetal demand for
nutrients, as seen in multiple pregnancies, could have different
mechanisms from that due to decreased maternal supply. Another
factor that may influence birth weight in monozygotic twins is
twin–twin transfusion syndrome, which can occur in two-thirds
of monozygotic twin pairs that are monochorionic, and may result
in birth-weight discordance and blood lipid level differences
through mechanisms not experienced by singletons (Lopiore et al.
2003). It was not possible to explore this aspect in the present
study, as chorionicity information was only recorded in twenty-
nine of the sixty monozygotic pairs. For postnatal growth it is also
possible that the pattern of catch-up growth seen in twins, which
mostly occurs in the first 2 years of life (Keet et al. 1986), may
have different effects to accelerated growth or overnutrition in
later childhood. Another way in which twins could differ from sin-
gletons is in infant feeding, as twins may be breast-fed less com-
monly or for shorter periods than singletons; breast-feeding in the
Caerphilly study was found to be associated with CHD mortality
and incidence (Martin et al. 2005). However, the subjects of the pre-
sent study were born at a time when infant formulae were more simi-
lar in composition to breast milk; in addition, twins within a pair are
likely to have been fed by the same method so the within-pair ana-
lyses are unlikely to be influenced by this issue.
Table 2. Birth weights and adult characteristics of twins and singleton controls
(Mean values and standard deviations)
Males Females
Twins (n 106) Singletons (n 46) Twins (n 156) Singletons (n 43)
Mean SD Mean SD Mean SD Mean SD
Birth weight (g) 2606·2 534·9 2955·6* 486·8 2398·9 526·0 2927·3* 696·0
Gestational age (weeks) 37·2 2·8 36·7 2·3 37·3 2·7 37·2 2·7
Current age (years) 36·2 8·7 35·7 9·8 30·5 8·7 31·1 9·41
Adult height (cm) 177·2 6·9 176·0 5·8 162·5 6·7 162·0 6·6
Adult weight (kg) 80·0 12·7 80·6 13·7 63·8 12·9 60·1 8·8
BMI (kg/m2) 25·5 3·7 26·0 3·9 24·2 4·8 22·9 3·0
Body fat (%) 20·0 5·8 21·0 5·7 29·8 8·2 28·4 6·7
*Mean value was significantly different from that for twins of the same sex (P,0·001).
Table 3. Fasting plasma lipid concentrations in twins and singleton controls
(Mean values and standard deviations)
Males Females
Twins (n 106) Singletons (n 46) Twins (n 156) Singletons (n 43)
Mean SD Mean SD Mean SD Mean SD
Total cholesterol (mmol/l) 4·95 1·03 5·18 0·93 4·73 1·04 4·71 1·04
HDL-cholesterol (mmol/l) 1·40 0·33 1·44 0·34 1·70 0·38 1·70 0·35
LDL-cholesterol (mmol/l) 3·01 0·87 3·18 0·79 2·63 0·88 2·60 0·87
Triacylglycerols (mmol/l) 1·19 0·78 1·23 0·58 0·89 0·52 0·90 0·38
Apo A1 (g/l) 1·35 0·23 1·40 0·23 1·46 0·25 1·51 0·21
Apo B (g/l) 1·13 0·32 1·16 0·33 0·96 0·32 0·97 0·31
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As there was no association between birth weight and lipid
levels in the unpaired twins it was not surprising that there was
no evidence for an attenuation of the effect in the within-pair
analysis in monozygotic v. dizygotic pairs. This is in contrast to
a recent study of adolescent twins (sixty-one monozygotic and
fifty-three dizygotic pairs), which found that low birth weight
was associated with high total and LDL-cholesterol in dizygotic
twin pairs, but with low total and LDL-cholesterol in monozygo-
tic twin pairs, suggesting a genetic effect on the association
(Ijzerman et al. 2001), although the unpaired analysis in twins
was not presented. It is not clear why the results of the two studies
differ; the major difference is that in the present study the subjects
were older, but the influence of birth weight on cardiovascular
risk factors might be expected to increase rather than decrease
with age. In the study of Ijzerman et al. (2001), birth weight
was ascertained from the mothers by questionnaire and zygosity
was determined by similarity questions, while in our subjects
birth weight was obtained from medical records and zygosity
was determined through sequential analysis based on DNA finger-
prints, so it is unlikely that errors in zygosity or birth weight could
account for the lack of effect in the present study.
In summary we found evidence for an inverse association
between birth weight and total and LDL-cholesterol in singletons
and for a genetic influence on lipid levels in the twins. No associ-
ation between birth weight and lipid levels was seen in unpaired
twins, and there was no significant difference in adult lipid levels
between the twins and the singleton controls. Differences in
growth patterns in prenatal and early postnatal life between
twins and singletons may help to identify the nature and timing
of early life influences on adult disease risk.
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